CD163 is a macrophage receptor that clears hemoglobin-haptoglobin complexes from blood, preventing oxidative damage and also ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to ...

The FDA bestows a Fast Track designation to Johnson & Johnson's nipocalimab for treating moderate-to-severe Sjogren's disease ...

In hemolytic anemia, red blood cells are destroyed faster ... Aplastic anemia usually results in the immune system damaging bone marrow stem cells. Other potential causes include: medications ...

A rarer but serious cause is aplastic anemia, where the bone marrow fails to produce enough red blood cells due to autoimmune disorders ... B12 deficiency anaemia. Hemolytic anaemia may present ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 11.76%, which has investors questioning if this is right time to sell.

House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for ...

Hemolytic anemia occurs when red blood cells are broken up in the bloodstream or in the spleen. It may be due to mechanical problems (leaky heart valves or aneurysms), infections, autoimmune ...

Immunovant (NASDAQ:IMVT – Free Report) had its price objective decreased by Bank of America from $38.00 to $33.00 in a ...

Immunovant (NASDAQ:IMVT – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in ...

While previous reports have noted autoimmune hemolytic anemia occurring after multiple cycles of immunotherapy, this article describes a case of a patient with advanced lung adenocarcinoma, who was ...